Home / Benchmarks / Medical Devices
Medical DevicesM&A Activity
Deal flow, active acquirers, and current market trend - based on 1,004real disclosed M&A transactions in the medical devices space. Run the calculator below to price your business at current multiples.
State of Medical DevicesM&A in 2026
The medical devices M&A market is tracked across 1,004 disclosed transactions in the ExitValue.ai database (418 with EBITDA disclosed, 978 with revenue). The current market trend is consolidating.
Active acquirers include Boston Scientific Corporation, Danaher Corporation, Agilent Technologies, Inc., Embecta. Recent named transactions: Penumbra, Inc. (2026); Masimo Corporation (2026); Biocare Medical, LLC (2026).
Premium valuations in medical devices are driven by fda 510(k) portfolio breadth (multiple cleared products = optionality for strategic buyer); recurring consumable revenue above 40% of total (razor / razor-blade economics); gpo contract base across premier / vizient / healthtrust (institutional channel locked).
What compresses valuations: single-product revenue concentration above 60% (regulatory or competitive risk amplified); fda recall history or warning-letter exposure (institutional buyers walk on this); single-distributor channel concentration (revenue interruption risk on contract loss).
Source: SEC filings, EDGAR 8-K/S-4, and verified press releases. Run the calculator below to see the specific multiples that apply to your business.
Recent named M&A deals in medical devices
Most-recent disclosed transactions. Click any deal for full detail (multiples, financials, source).
Sourced from SEC filings, EDGAR 8-K/S-4, and verified press releases.
Get an instant valuation for your medical devices
Backed by the same 1,004 disclosed transactions, adjusted for your specific size and margin.
Get your full valuation analysis
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
What drives a premium valuation
- ●FDA 510(k) portfolio breadth (multiple cleared products = optionality for strategic buyer)
- ●Recurring consumable revenue above 40% of total (razor / razor-blade economics)
- ●GPO contract base across Premier / Vizient / HealthTrust (institutional channel locked)
What compresses valuation
- ●Single-product revenue concentration above 60% (regulatory or competitive risk amplified)
- ●FDA recall history or warning-letter exposure (institutional buyers walk on this)
- ●Single-distributor channel concentration (revenue interruption risk on contract loss)
Medical Devices valuation: common questions
How is a medical devices business valued?
Medical Devices businesses are valued by benchmarking against comparable completed M&A transactions, then adjusting for the specific business. Owner-operator practices are typically priced on an earnings or seller-discretionary-earnings basis, while businesses at platform scale shift toward institutional earnings-multiple methodology. The ExitValue.ai engine selects the methodology that the comparable deal set actually used and adjusts for margin quality, growth, owner dependency, customer concentration, and recurring-revenue mix.
What drives medical devices valuation?
The biggest value levers in medical devices are recurring or repeat revenue, owner independence (the business runs without the founder), customer diversification (no single client dominates), a credible growth trajectory, and operating-margin quality relative to the vertical. In this space specifically, buyers pay up for fda 510(k) portfolio breadth (multiple cleared products = optionality for strategic buyer); recurring consumable revenue above 40% of total (razor / razor-blade economics); gpo contract base across premier / vizient / healthtrust (institutional channel locked).
How many medical devices M&A deals are tracked?
ExitValue.ai tracks 1,004 disclosed medical devices M&A transactions, 418 with EBITDA disclosed, 978 with revenue disclosed, sourced from SEC filings, EDGAR 8-K/S-4 documents, and verified press releases and refreshed daily. Current market trend: consolidating.
Who buys medical devices businesses?
Medical Devices businesses are acquired by strategic acquirers (larger operators in the same space), and private-equity platforms and roll-up consolidators, and unknown. Recent named acquirers include Boston Scientific Corporation, Danaher Corporation, Agilent Technologies, Inc., Embecta.
What is my medical devices business worth?
Run the ExitValue.ai medical devices calculator to see your business priced against the 1,004 disclosed medical devices transactions in the database. The engine applies adjustments for margin, growth, owner dependency, customer concentration, and recurring revenue mix to produce a tight range around the most-likely transaction value.
More on medical devices valuations
- Medical Devices valuation calculator· head-term variant
- Who buys medical devices businesses?· active buyers
- Recent deal: Owen Mumford Holdings· comparable transaction
- Who acquired Owen Mumford Holdings?· buyer profile
- How to value a medical devices· long-form guide
Methodology details: how ExitValue computes valuation ranges · full medical devices calculator